LLASHNEWSMedical aesthetics media & sourcingRequest Quote
RegulatoryAesthetic DevicesInjectables

【South Korea】South Korea Launches K-Wellness Tourism Push Under New Healing Industry Act

Source image preserved for article context.
Editor's note

This report signals a formal regulatory framework under the Healing Tourism Industry Act, creating structured B2B opportunities for overseas medical aesthetics buyers. Sourcing from government-backed venues and subsidies, the legislative shift offers clearer compliance pathways and potential procurement tenders for device, injectable, and skincare suppliers, while the certification system may impact import requirements.

South Korea is rolling out a government-backed wellness tourism strategy under the newly enacted Healing Tourism Industry Act, selecting 20 premier sites for global promotion with up to 50 million won ($36,300) in subsidies each. For overseas medical aesthetics buyers and distributors, this signals growing institutional support for high-tech beauty spas, traditional Korean medicine, and wellness retreats—potentially opening new B2B opportunities in clinic partnerships, device procurement, and supply-chain integration.

Legislative framework and market signal

The Healing Tourism Industry Act, effective spring 2026, establishes a formal regulatory and quality-management system for healing services, including certified professional training and designated regional "healing tourism zones." This institutionalization creates a structured environment for foreign investors and suppliers to enter the Korean wellness market with clearer compliance pathways and government backing.

Selected venues and supply-chain relevance

The 20 chosen sites span traditional Korean medicine, high-tech beauty spas, forest retreats, and hydrotherapy programs. Notable venues include Sayuwon meditation park in Daegu, Awon Hanok in Wanju (a BTS-linked property), and WE Hotel on Jeju Island with clinically-backed hydrotherapy. These facilities will require advanced aesthetic devices, injectables, skincare products, and consumables—creating procurement opportunities for overseas suppliers.

Government funding and infrastructure upgrades

Each selected venue receives up to 50 million won for multilingual digital infrastructure, global advertising, and localized content development across six core areas. This funding will likely drive demand for clinic-grade equipment, packaging solutions, and consumables tailored to international guests, benefiting distributors and OEM partners.

What buyers should watch

Overseas aesthetic device manufacturers, injectable suppliers, and skincare OEMs should monitor Korea's Healing Tourism Industry Act for new procurement tenders and partnership models. The government's focus on high-tech beauty spas and traditional Korean medicine suggests opportunities for laser systems, energy-based devices, and cosmeceutical formulations. Distributors may explore direct collaborations with designated wellness sites or regional tourism zones.

Regulatory and channel signals

The Act's certification system for healing professionals and quality standards for services may influence import requirements for medical aesthetics products. Suppliers should prepare for potential alignment with Korean Ministry of Food and Drug Safety (MFDS) regulations and consider early engagement with designated zone operators to secure preferred vendor status.

Source: Read the original report | Published: June 01, 2026